Tango Therapeutics (TNGX) Competitors $3.81 -0.08 (-2.06%) (As of 10:02 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TNGX vs. IMCR, NTLA, KNSA, OCUL, TVTX, NRIX, PRAX, ARQT, RCUS, and SNDXShould you be buying Tango Therapeutics stock or one of its competitors? The main competitors of Tango Therapeutics include Immunocore (IMCR), Intellia Therapeutics (NTLA), Kiniksa Pharmaceuticals (KNSA), Ocular Therapeutix (OCUL), Travere Therapeutics (TVTX), Nurix Therapeutics (NRIX), Praxis Precision Medicines (PRAX), Arcutis Biotherapeutics (ARQT), Arcus Biosciences (RCUS), and Syndax Pharmaceuticals (SNDX). These companies are all part of the "pharmaceutical products" industry. Tango Therapeutics vs. Immunocore Intellia Therapeutics Kiniksa Pharmaceuticals Ocular Therapeutix Travere Therapeutics Nurix Therapeutics Praxis Precision Medicines Arcutis Biotherapeutics Arcus Biosciences Syndax Pharmaceuticals Tango Therapeutics (NASDAQ:TNGX) and Immunocore (NASDAQ:IMCR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, community ranking, profitability, dividends and earnings. Does the MarketBeat Community favor TNGX or IMCR? Immunocore received 37 more outperform votes than Tango Therapeutics when rated by MarketBeat users. Likewise, 73.56% of users gave Immunocore an outperform vote while only 72.97% of users gave Tango Therapeutics an outperform vote. CompanyUnderperformOutperformTango TherapeuticsOutperform Votes2772.97% Underperform Votes1027.03% ImmunocoreOutperform Votes6473.56% Underperform Votes2326.44% Do analysts rate TNGX or IMCR? Tango Therapeutics presently has a consensus price target of $13.14, suggesting a potential upside of 237.86%. Immunocore has a consensus price target of $69.18, suggesting a potential upside of 112.93%. Given Tango Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Tango Therapeutics is more favorable than Immunocore.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tango Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00Immunocore 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.62 Which has more volatility and risk, TNGX or IMCR? Tango Therapeutics has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Immunocore has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Do institutionals and insiders believe in TNGX or IMCR? 79.0% of Tango Therapeutics shares are owned by institutional investors. Comparatively, 84.5% of Immunocore shares are owned by institutional investors. 6.3% of Tango Therapeutics shares are owned by insiders. Comparatively, 9.1% of Immunocore shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is TNGX or IMCR more profitable? Immunocore has a net margin of -15.87% compared to Tango Therapeutics' net margin of -284.42%. Immunocore's return on equity of -12.84% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tango Therapeutics-284.42% -49.64% -32.00% Immunocore -15.87%-12.84%-5.09% Which has stronger earnings & valuation, TNGX or IMCR? Immunocore has higher revenue and earnings than Tango Therapeutics. Immunocore is trading at a lower price-to-earnings ratio than Tango Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTango Therapeutics$43.38M9.63-$101.74M-$1.18-3.30Immunocore$296.31M5.49-$55.29M-$0.95-34.20 Does the media prefer TNGX or IMCR? In the previous week, Tango Therapeutics and Tango Therapeutics both had 4 articles in the media. Immunocore's average media sentiment score of 1.48 beat Tango Therapeutics' score of 1.20 indicating that Immunocore is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tango Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Immunocore 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryImmunocore beats Tango Therapeutics on 12 of the 17 factors compared between the two stocks. Ad Chaikin AnalyticsBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... They're minting new billionaires. The number of American billionaires has skyrocketed over last year – their wealth hitting a record $12.1 trillion – thanks to the Nasdaq's extraordinary outperformance. But now, after two years of near-vertical gains...New warnings out of Wall Street suggest that the winds are about to change. Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNGX vs. The Competition Export to ExcelMetricTango TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$417.86M$7.05B$5.31B$8.94BDividend YieldN/A7.93%5.23%4.05%P/E Ratio-3.3011.28136.9718.02Price / Sales9.63242.101,455.46155.72Price / CashN/A62.0541.6738.60Price / Book1.8310.647.336.66Net Income-$101.74M$152.36M$117.74M$224.93M7 Day Performance1.30%3.48%3.38%2.50%1 Month Performance-24.47%-1.31%2.50%10.23%1 Year Performance-49.87%31.72%35.96%30.14% Tango Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNGXTango Therapeutics3.4824 of 5 stars$3.81-2.1%$13.14+245.0%-49.9%$409.27M$36.53M-3.2390Positive NewsIMCRImmunocore2.7373 of 5 stars$32.63-0.3%$69.18+112.0%-38.3%$1.63B$296.31M-34.46497Positive NewsNTLAIntellia Therapeutics4.2783 of 5 stars$15.64+0.1%$54.94+251.3%-49.0%$1.59B$36.28M-2.87600KNSAKiniksa Pharmaceuticals2.8442 of 5 stars$22.05-0.1%$36.60+66.0%+30.0%$1.59B$384.10M-157.29220News CoveragePositive NewsOCULOcular Therapeutix4.0829 of 5 stars$9.87-0.2%$16.71+69.3%+264.6%$1.55B$58.44M-7.49267Analyst ForecastTVTXTravere Therapeutics2.5242 of 5 stars$19.71+4.8%$22.62+14.7%+204.8%$1.54B$203.45M-4.27460NRIXNurix Therapeutics2.8191 of 5 stars$21.58-2.4%$29.40+36.2%+211.0%$1.53B$56.42M-7.60300Positive NewsGap UpPRAXPraxis Precision Medicines2.9865 of 5 stars$79.66-0.6%$146.33+83.7%+343.4%$1.48B$1.61M-7.78110News CoveragePositive NewsARQTArcutis Biotherapeutics1.3719 of 5 stars$12.52-4.0%$15.50+23.8%+523.9%$1.47B$138.71M-7.28150Short Interest ↓RCUSArcus Biosciences2.4477 of 5 stars$15.84+2.6%$34.00+114.6%-0.8%$1.45B$117M-4.90500SNDXSyndax Pharmaceuticals4.1835 of 5 stars$16.78+0.4%$37.64+124.3%+0.8%$1.43B$139.71M-4.61110 Related Companies and Tools Related Companies IMCR Competitors NTLA Competitors KNSA Competitors OCUL Competitors TVTX Competitors NRIX Competitors PRAX Competitors ARQT Competitors RCUS Competitors SNDX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNGX) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNGX Stock Alerts